Neoadjuvant Chemotherapy Alters Neuropilin-1, PlGF, and SNAI1 Expression Levels and Predicts Breast Cancer Patients Response

Neoadjuvant Chemotherapy Alters Neuropilin-1, PlGF, and SNAI1 Expression Levels and Predicts Breast Cancer Patients Response

<p dir="ltr">Circulating proteins hold a potential benefit as biomarkers for precision medicine. Previously, we showed that systemic levels of neuropilin-1 (NRP-1) and its associated molecules correlated with poor-prognosis breast cancer. To further identify the role of NRP-1 and its...

Full description

Saved in:
Bibliographic Details
Main Author: Noura Al-Zeheimi (5177066) (author)
Other Authors: Adviti Naik (673163) (author), Charles Saki Bakheit (6632636) (author), Marwa Al Riyami (18618901) (author), Adil Al Ajarrah (18618904) (author), Suaad Al Badi (18618907) (author), Khalid Al Baimani (18618910) (author), Kamran Malik (6632651) (author), Zamzam Al Habsi (18618913) (author), Mansour S. Al Moundhri (18618916) (author), Sirin A. Adham (6632660) (author)
Published: 2019
Subjects:
Biomedical and clinical sciences
Oncology and carcinogenesis
neuropilin-1
biomarker
breast
blood
response
neoadjuvant
SNAI1
PlGF
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items